![Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire](https://mms.businesswire.com/media/20210728005045/en/894218/5/Teva_2020_Economic_Impact_Report_Infographic_26_July_2021.jpg)
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire
![Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Image - Image of american, generics: 187803275 Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Image - Image of american, generics: 187803275](https://thumbs.dreamstime.com/b/kyiv-ukraine-may-gastroenterology-generic-drug-omeprazole-teva-box-closeup-white-teva-pharmaceuticals-american-israeli-187803275.jpg)
Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Image - Image of american, generics: 187803275
![Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults ADDING MULTIMEDIA | BioSpace Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults ADDING MULTIMEDIA | BioSpace](https://mms.businesswire.com/media/20180914005613/en/678526/4/AJOVY+Image.jpg)